Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study
This latent-class analysis identified a high-risk cluster of patients with severe, persistent post-immunotherapy QOL deterioration. Screening relevant patient-level characteristics may inform tailored interventions to mitigate the detrimental impact of immunotherapy and preserve QOL.
Authors
- Fei-Chen Lu
- Feng-Juan Zhao
- Xuemei You (ORCID: https://orcid.org/0000-0002-7704-1703)
- Rong‐Rui Huo (ORCID: https://orcid.org/0000-0002-3723-9619)
- Fan-Rong Li
Institutions
- Guangxi Medical University (CN)
- Guangxi Center for Disease Prevention and Control (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.3389/fimmu.2024.1463655
- Citations
- 5
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China